Molecular Breast Imaging for Screening in Dense Breasts: State of the Art and Future Directions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27762607.
- Also identified by DOI 10.2214/AJR.16.17131.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purposes of this review are to discuss the motivation for supplemental screening, to address molecular breast imaging (MBI) radiation dose concerns, and to provide an updated guide to current MBI technology, clinical protocols, and screening performance. Future directions of MBI are also discussed. MBI offers detection of mammographically occult cancers in women with dense breasts. Although MBI has been under investigation for nearly 15 years, it has yet to gain widespread adoption in breast screening.
Medical subject headings
- Biomarkers, Tumor
- Breast Neoplasms
- Early Detection of Cancer
- Mammography
- Molecular Imaging